1. Home
  2. ARVN vs TRNS Comparison

ARVN vs TRNS Comparison

Compare ARVN & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.04

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Logo Transcat Inc.

TRNS

Transcat Inc.

HOLD

Current Price

$92.29

Market Cap

542.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
TRNS
Founded
2015
1964
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
658.2M
542.9M
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
ARVN
TRNS
Price
$8.04
$92.29
Analyst Decision
Buy
Strong Buy
Analyst Count
19
1
Target Price
$15.05
$116.00
AVG Volume (30 Days)
680.3K
198.8K
Earning Date
05-04-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
N/A
0.57
Revenue
$262,600,000.00
$331,877,000.00
Revenue This Year
N/A
$21.75
Revenue Next Year
N/A
$7.55
P/E Ratio
N/A
$157.25
Revenue Growth
N/A
19.20
52 Week Low
$6.06
$50.23
52 Week High
$14.22
$94.76

Technical Indicators

Market Signals
Indicator
ARVN
TRNS
Relative Strength Index (RSI) 46.65 60.67
Support Level $7.35 $68.27
Resistance Level $10.18 $94.76
Average True Range (ATR) 0.41 4.11
MACD 0.17 -0.34
Stochastic Oscillator 70.20 70.71

Price Performance

Historical Comparison
ARVN
TRNS

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About TRNS Transcat Inc.

Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.

Share on Social Networks: